Pfizer's Covid-19 vaccine trial data shows long-term efficacy in adolescents
kathmandupost.com
. 2 year ago
The vaccine was authorized for emergency use in people aged 12-15 years by the US Food & Drug Administration in May, and granted full approval for use in people aged 16 and above in August. Pfizer...
Comment
Liked by: